Interpace Biosciences®, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Investments in Marketable Securities (Tables)

Investments in Marketable Securities (Tables)

12 Months Ended

Dec. 31, 2015

Investments, Debt and Equity Securities [Abstract]

Investments Classified by Contractual Maturity Date [Table Text Block]

At December 31, 2015 and 2014, held-to-maturity investments included:



			Maturing						Maturing
	December 31, 2015		within 1 year		after 1 year through 3 years		December 31, 2014		within 1 year		after 1 year through 3 years
Cash/money market funds	$	47	$	47	$	—	$	204	$	204	$	—
US Treasury securities	1,115		341		774		1,070		105		965
Government agency securities	131		—		131		317		225		92
Total	$	1,293	$	388	$	905	$	1,591	$	534	$	1,057

Held-to-maturity Securities [Table Text Block]

At December 31, 2015 and December 31, 2014, held-to-maturity investments were recorded in the following accounts:



	December 31, 2015		December 31, 2014
Other current assets	$	388	$	534
Other long-term assets	905		1,057
Total	$	1,293	$	1,591

- Definition

Tabular disclosure of all investments in certain debt and equity securities for which the entity has the positive intent and ability to hold until maturity.

+ References + Details